2025. Targeting Anti-Cancer Lead Compounds: A Strategic Approach to Isolate and Characterize by NMR, Mass, FTIR from the Complex Matrix of Tripterygium wilfordii. Vascular and Endovascular Review. 8, 12s (Nov. 2025), 58–71.